Related references
Note: Only part of the references are listed.Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection
Wenxu Jia et al.
EMERGING MICROBES & INFECTIONS (2019)
Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice
Bo Li et al.
MICROBIAL PATHOGENESIS (2018)
One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus
Christoph Wirblich et al.
JOURNAL OF VIROLOGY (2017)
MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques
Chong Wang et al.
ONCOTARGET (2017)
DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice
Hang Chi et al.
VACCINE (2017)
Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein
Sawsan S. Al-amri et al.
SCIENTIFIC REPORTS (2017)
Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus
Joel N. Maslow
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Newcastle disease virus-based MERS-CoV candidate vaccine elicits high-level and lasting neutralizing antibodies in Bactrian camels
Liu Ren-qiang et al.
JOURNAL OF INTEGRATIVE AGRICULTURE (2017)
Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus
Jie Zhou et al.
SCIENCE ADVANCES (2017)
Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice
Chong Wang et al.
ANTIVIRAL RESEARCH (2017)
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
Bart L. Haagmans et al.
SCIENCE (2016)
Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications
C. Michon et al.
MICROBIAL CELL FACTORIES (2016)
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Shuo Su et al.
TRENDS IN MICROBIOLOGY (2016)
Immunogenicity and immunoprotection of porcine circovirus type 2 (PCV2) Cap protein displayed by Lactococcus lactis
Peng-cheng Li et al.
VACCINE (2016)
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
Yan Li et al.
CELL RESEARCH (2015)
Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus
Xiaojuan Guo et al.
IMMUNOLOGY (2015)
Shigella IpaB and IpaD displayed on L-lactis bacterium-like particles induce protective immunity in adult and infant mice
Shannon J. Heine et al.
IMMUNOLOGY AND CELL BIOLOGY (2015)
A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform
Anna H. Malczyk et al.
JOURNAL OF VIROLOGY (2015)
Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein
Asisa Volz et al.
JOURNAL OF VIROLOGY (2015)
MERS in South Korea and China: a potential outbreak threat?
Shuo Su et al.
LANCET (2015)
A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates
Karuppiah Muthumani et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Receptor-binding domain-based subunit vaccines against MERS-CoV
Naru Zhang et al.
VIRUS RESEARCH (2015)
Immune responses to vaccines involving a combined antigen-nanoparticle mixture and nanoparticle-encapsulated antigen formulation
Weifeng Zhang et al.
BIOMATERIALS (2014)
Current advancements and potential strategies in the development of MERS-CoV vaccines
Naru Zhang et al.
EXPERT REVIEW OF VACCINES (2014)
Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen
Jiaming Lan et al.
PLOS ONE (2014)
Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments-The importance of immunofocusing in subunit vaccine design
Cuiqing Ma et al.
VACCINE (2014)
Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
Cuiqing Ma et al.
VACCINE (2014)
The emergence of the Middle East Respiratory Syndrome coronavirus
Shauna Milne-Price et al.
PATHOGENS AND DISEASE (2014)
Fusion protein linkers: Property, design and functionality
Xiaoying Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development (vol 87, pg 9939, 2013)
Lanying Du et al.
JOURNAL OF VIROLOGY (2013)
The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies
Huihui Mou et al.
JOURNAL OF VIROLOGY (2013)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus
Abdullah Assiri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Protective and Safe Intranasal RSV Vaccine Based on a Recombinant Prefusion-Like Form of the F Protein Bound to Bacterium-Like Particles
Alan Rigter et al.
PLOS ONE (2013)
A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
Lanying Du et al.
PLOS ONE (2013)
Bacterium-like particles as multi-epitope delivery platform for Plasmodium berghei circumsporozoite protein induce complete protection against malaria in mice
Krystelle Nganou-Makamdop et al.
MALARIA JOURNAL (2012)
Efficacy of intranasal and spray delivery of adjuvanted live vaccine against infectious bronchitis virus in experimentally infected poultry
Sebastien Deville et al.
5TH VACCINE AND ISV ANNUAL GLOBAL CONGRESS (2012)
Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection
K. Ramirez et al.
MUCOSAL IMMUNOLOGY (2010)
LysM, a widely distributed protein motif for binding to (peptido)glycans
Girbe Buist et al.
MOLECULAR MICROBIOLOGY (2008)
System using tandem repeats of the cA peptidoglycan-binding domain from Lactococcus lactis for display of both N- and C-terminal fusions on cell surfaces of lactic acid bacteria
Kenji Okano et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2008)
Development of lactococcal GEM-based pneumococcal vaccines
Sandrine A. L. Audouy et al.
VACCINE (2007)
CD69 expression as an index of T-cell function: assay standardization, validation and use in monitoring immune recovery
W. B. Lindsey et al.
CYTOTHERAPY (2007)
Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations
R. Ramasamy et al.
VACCINE (2006)
Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria
ML van Roosmalen et al.
METHODS (2006)
Novel surface display system for proteins on non-genetically modified gram-positive bacteria
T Bosma et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2006)
Divergent immunoglobulin G subclass activity through selective Fc receptor binding
F Nimmerjahn et al.
SCIENCE (2005)
AcmA of Lactococcus lactis is an N-acetylglucosaminidase with an optimal number of LysM domains for proper functioning
A Steen et al.
FEBS JOURNAL (2005)
CD69 is an immunoregulatory molecule induced following activation
D Sancho et al.
TRENDS IN IMMUNOLOGY (2005)
Microbial cell-surface display
SY Lee et al.
TRENDS IN BIOTECHNOLOGY (2003)
The structure of a LysM domain from E-coli membrane-bound lytic murein transglycosylase D (MltD)
A Bateman et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Share Paper
